226 related articles for article (PubMed ID: 34670511)
21. Using TILs to Predict Therapeutic Effect of Chemotherapy (Pertuzumab, Trastuzumab, Docetaxel) on HER2-positive Breast Cancer.
Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
Anticancer Res; 2017 Oct; 37(10):5623-5630. PubMed ID: 28982879
[TBL] [Abstract][Full Text] [Related]
22. Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden.
Asano Y; Kashiwagi S; Goto W; Takada K; Takahashi K; Hatano T; Noda S; Takashima T; Onoda N; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
BMC Cancer; 2017 Dec; 17(1):888. PubMed ID: 29282021
[TBL] [Abstract][Full Text] [Related]
23. Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer.
Takada K; Kashiwagi S; Goto W; Asano Y; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
J Transl Med; 2018 Nov; 16(1):318. PubMed ID: 30454008
[TBL] [Abstract][Full Text] [Related]
24. The effect of body mass index on major outcomes after vascular surgery.
Galyfos G; Geropapas GI; Kerasidis S; Sianou A; Sigala F; Filis K
J Vasc Surg; 2017 Apr; 65(4):1193-1207. PubMed ID: 27876519
[TBL] [Abstract][Full Text] [Related]
25. Brief Post-Surgical Stress Management Reduces Pro-Inflammatory Cytokines in Overweight and Obese Breast Cancer Patients Undergoing Primary Treatment.
Ream M; Saez-Clarke E; Taub C; Diaz A; Frasca D; Blomberg BB; Antoni MH
Front Biosci (Landmark Ed); 2022 May; 27(5):148. PubMed ID: 35638415
[TBL] [Abstract][Full Text] [Related]
26. Feasibility of purely laparoscopic resection of locally advanced rectal cancer in obese patients.
Oyasiji T; Baldwin K; Katz SC; Espat NJ; Somasundar P
World J Surg Oncol; 2012 Jul; 10():147. PubMed ID: 22799628
[TBL] [Abstract][Full Text] [Related]
27. Is the Obesity Paradox in Cardiac Surgery Really a Myth? Effect of Body Mass Index on Early and Late Clinical Outcomes.
Burgos LM; Gil Ramírez A; Seoane L; Espinoza J; Furmento JF; Costabel JP; Benzadón M; Navia D
J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):492-498. PubMed ID: 32423731
[TBL] [Abstract][Full Text] [Related]
28. Dissimilar patterns of tumor-infiltrating immune cells at the invasive tumor front and tumor center are associated with response to neoadjuvant chemotherapy in primary breast cancer.
König L; Mairinger FD; Hoffmann O; Bittner AK; Schmid KW; Kimmig R; Kasimir-Bauer S; Bankfalvi A
BMC Cancer; 2019 Feb; 19(1):120. PubMed ID: 30717704
[TBL] [Abstract][Full Text] [Related]
29. Impact of body mass index on pathological response after neoadjuvant chemotherapy: results from the I-SPY 2 trial.
Wang H; Yee D; Potter D; Jewett P; Yau C; Beckwith H; Watson A; O'Grady N; Wilson A; Brain S; Pohlmann P; ; Blaes A
Breast Cancer Res Treat; 2024 Apr; 204(3):589-597. PubMed ID: 38216819
[TBL] [Abstract][Full Text] [Related]
30. A Multicenter Study of the Impact of Body Mass Index (BMI) on the incidence of Pathologic Complete Response (pCR) Among Saudi Patients with locally advanced Breast cancer (LABC) post Neoadjuvant Chemotherapy (NAC).
Al-Saleh K; Abd El-Aziz N; Ali A; Abo Zeed W; Salah T; Elsamany S; Rasmy A; El Farargy O; Husain S; Al-Rikabi A; Alsaeed E; Aldiab A; Abd El-Warith A
Gulf J Oncolog; 2019 May; 1(30):33-42. PubMed ID: 31242980
[TBL] [Abstract][Full Text] [Related]
31. Does obesity have an effect on outcomes in triple-negative breast cancer?
Mowad R; Chu QD; Li BD; Burton GV; Ampil FL; Kim RH
J Surg Res; 2013 Sep; 184(1):253-9. PubMed ID: 23768767
[TBL] [Abstract][Full Text] [Related]
32. Impaired HDL-associated enzymes and proteins in children and adolescents with weight disorders and their association with novel cardiometabolic indexes.
Martin M; Davico B; Verona MF; Tetzlaff WF; Lozano Chiappe E; Gilligan L; Jimenez G; Gomez Rosso L; Ballerini G; Boero L; Verona J; Brites F
Nutr Metab Cardiovasc Dis; 2023 Dec; 33(12):2517-2526. PubMed ID: 37793940
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathologic and Prognostic Significance of Body Mass Index (BMI) among Breast Cancer Patients in Western China: A Retrospective Multicenter Cohort Based on Western China Clinical Cooperation Group (WCCCG).
Wang K; Wu YT; Zhang X; Chen L; Zhu WM; Zhang AJ; Zheng K; Yin XD; Li F; Kong LQ; Ma BL; Li H; Liu JP; Jiang J; Li ZY; Shi Y; Ren GS; Li HY
Biomed Res Int; 2019; 2019():3692093. PubMed ID: 31119166
[TBL] [Abstract][Full Text] [Related]
34. The relationship between ring-type dedicated breast PET and immune microenvironment in early breast cancer.
Sasada S; Shiroma N; Goda N; Kajitani K; Emi A; Masumoto N; Kadoya T; Arihiro K; Okada M
Breast Cancer Res Treat; 2019 Oct; 177(3):651-657. PubMed ID: 31267329
[TBL] [Abstract][Full Text] [Related]
35. Tumor-infiltrating lymphocytes (TILs) in ER+/HER2- breast cancer.
Criscitiello C; Vingiani A; Maisonneuve P; Viale G; Viale G; Curigliano G
Breast Cancer Res Treat; 2020 Sep; 183(2):347-354. PubMed ID: 32621251
[TBL] [Abstract][Full Text] [Related]
36. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.
Kwan ML; Chen WY; Kroenke CH; Weltzien EK; Beasley JM; Nechuta SJ; Poole EM; Lu W; Holmes MD; Quesenberry CP; Pierce JP; Shu XO; Caan BJ
Breast Cancer Res Treat; 2012 Apr; 132(2):729-39. PubMed ID: 22187127
[TBL] [Abstract][Full Text] [Related]
37. Relationship between serum lipid levels and the immune microenvironment in breast cancer patients: a retrospective study.
Goto W; Kashiwagi S; Kamei Y; Watanabe C; Aomatsu N; Ikeda K; Ogawa Y; Hirakawa K; Ohira M
BMC Cancer; 2022 Feb; 22(1):167. PubMed ID: 35164691
[TBL] [Abstract][Full Text] [Related]
38. Tumor-Infiltrating Lymphocytes in a Contemporary Cohort of Women with Ductal Carcinoma In Situ (DCIS).
Darvishian F; Ozerdem U; Adams S; Chun J; Pirraglia E; Kaplowitz E; Guth A; Axelrod D; Shapiro R; Price A; Troxel A; Schnabel F; Roses D
Ann Surg Oncol; 2019 Oct; 26(10):3337-3343. PubMed ID: 31240590
[TBL] [Abstract][Full Text] [Related]
39. Effect of obesity on presentation of breast cancer.
Porter GA; Inglis KM; Wood LA; Veugelers PJ
Ann Surg Oncol; 2006 Mar; 13(3):327-32. PubMed ID: 16485153
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer.
Park SH; Lee S; Song JH; Choi S; Cho M; Kwon IG; Son T; Kim HI; Cheong JH; Hyung WJ; Choi SH; Noh SH; Choi YY
Eur J Surg Oncol; 2020 Apr; 46(4 Pt A):620-625. PubMed ID: 31668977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
